How Genomics Can Help Fight The Pandemic

The video discusses 23andMe's progress as a public company, its research on COVID-19, and collaboration with GSK. It covers public health messaging, vaccine recommendations, and the importance of vaccination. The company is exploring genetic links to COVID-19, including long COVID, and is involved in drug discovery with GSK. It also highlights research in women's health and the potential of polygenic risk scores to predict disease risk. The 23andMe Plus service aims to expand its role in personal health management.

How does the collaboration between 23andMe and GSK aim to advance drug discovery?

What insights have been gained from research on reproductive aging in women?

In what ways can polygenic risk scores help in disease prevention and treatment?